Top Markets
Coin of the day
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rangering i aksjer #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Aksjekurs
$2.22
Sist synkronisert: 2026-08-21
Markedsverdi
$117.70M
Endring (1 dag)
2.69%
Endring (1 år)
17.26%
Land
SE
Handel SynAct Pharma AB (SYNACT)

Kategori

Aksjeprishistorikk for SynAct Pharma AB (SYNACT)
Høyeste sluttskurs: $2.19 den 2026-08-01

Laveste sluttskurs: $0.56 den 2016-07-01
Aksjeprishistorikk for SynAct Pharma AB fra 2016 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -7.35%
2025 144.78%
2024 17.64%
2023 -89.62%
2022 -48.77%
2021 236.22%
2020 376.82%
2019 16.49%
2018 -27.27%
2017 82.38%
2016 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.69 -14.89%
AU
$770.19 8.98%
CH